BW A1433

Known as: BWA1433, BW-A1433, BWA-1433 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2003
012319962003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
We recently reported the identification of a novel human adenosine A3 receptor-selective agonist, (2S,3S,4R,5R)-3-amino-5-[6-[5… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2001
2001
Earlier studies have shown that whole body adenosine receptor antagonism increases skeletal muscle insulin sensitivity in insulin… (More)
Is this relevant?
1998
1998
OBJECTIVE The aim of this study was to characterize the adenosine A3 receptor agonist, N6-(3-chlorobenzyl)-5'-N… (More)
Is this relevant?
1998
1998
Previous studies have shown that treatment of obese Zucker rats with the adenosine receptor antagonist 1,3-dipropyl-8-(p-acrylic… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1998
1998
Although ischemic preconditioning (IP) in several species can be pharmacologically mimicked by selective adenosine A1 or A3… (More)
Is this relevant?
1997
1997
OBJECTIVE The aim of this study was to determine whether selective activation of the adenosine A3 receptor reduces infarct size… (More)
  • table 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
1997
1997
Ischemic preconditioning reduces post-ischemic myocardial injury by activating myocellular adenosine A1 receptors. Adenosine A3… (More)
Is this relevant?
1997
1997
1. In this study we have characterized the receptor(s) in the rat mesenteric artery mediating relaxant responses to adenosine and… (More)
Is this relevant?
1996
1996
1. The presence of A2 receptors mediating relaxation in the rat isolated aorta has been previously demonstrated. However, agonist… (More)
Is this relevant?